| Application no. and date | 20760858.9 (espacenet) (Federated) (European Patent Register), 20200821 | | Patent/reg. no. and date | DK/EP 3947685, 20220713 | | Publication date | 20220209 | | Priority no. and date | GB 201912191, 20190824 | | EP pub. no. and date |
EP 3947685 20220209 | | Effective date | | | Applicant/owner | InDex Pharmaceuticals AB, Berzelius väg 13
171 65 Solna, SE | | Applicant ref. no. | V446942DK00 | | Inventor | ZERHOUNI, Peter, c/o InDex Pharmaceuticals AB
Berzelius väg 13
171 65 Solna, SE,
SANDWALL, Pernilla, c/o InDex Pharmaceuticals AB
Berzelius väg 13
171 65 Solna, SE,
KNITTEL, Thomas, c/o InDex Pharmaceuticals AB
Berzelius väg 13
171 65 Solna, SE | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/7125 (2006.01) , A61P 1/00 (2006.01) , A61P 37/04 (2006.01) , C12N 15/117 (2010.01) | | Title | Oligonukleotidbaseret terapi mod ulcerøs colitis | | Int. application no. | EP2020073566 | | Int. publication no. | WO2021037764 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
